JPRN-UMIN000025820已完成未知
Personalized medication for overactive bladder with imidafenacin treatment - PERMIT study
ara Medical University0 个研究点目标入组 100 人开始时间: 2017年3月15日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •- Urinary retention within the last 12 months - Post-void residual urine 100mL and more - Indwelling catheter or Intermittent catheterization - Sleep apnea syndrome, Restless legs syndrome or insomnia - acute urinary infection
研究者
相似试验
招募中
3 期
Overactive bladder treatment by Intravaginal injection of botulinum toxin AIRCT20211203053261N1Shahid Beheshti University of Medical Sciences50
已完成
3 期
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive BladderOveractive BladderNCT04917315Jeil Pharmaceutical Co., Ltd.210
招募中
不适用
Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MSMultiple SclerosisOveractive BladderNeurogenic BladderNCT06072703The Methodist Hospital Research Institute29
尚未招募
不适用
Integrated Overactive Bladder Clinical Trial in clinical practice IIIbladder overactivityurgency1000499410038365NL-OMON38014Medisch Universitair Ziekenhuis Maastricht166
终止
2 期
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive BladderUrge Urinary IncontinenceOveractive BladderNCT02129816University of Zurich9